Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone...

por Dimopoulos, Meletios, Wang, Michael, Maisnar, Vladimir, Minarik, Jiri, Bensinger, William, Mateos, Maria-Victoria, Obreja, Mihaela, Blaedel, Julie, Moreau, Philippe
Publicado 2018

P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

por Popková, Tereza, Pour, Ludek, Spicka, Ivan, Radocha, Jakub, Jungova, Alexandra, Minarik, Jiri, Pavlíček, Petr, Jelínek, Tomas, Krejčí, Marta, Straub, Jan, Maisnar, Vladimir, Dekojová, Tereza, Pika, Tomáš, Soukup, Jan, Pospíšilová, Lenka, Hájek, Roman
Publicado 2023

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas

por Stork, Martin, Sevcikova, Sabina, Jelinek, Tomas, Minarik, Jiri, Radocha, Jakub, Pika, Tomas, Pospisilova, Lenka, Spicka, Ivan, Straub, Jan, Pavlicek, Petr, Jungova, Alexandra, Knechtova, Zdenka, Sandecka, Viera, Maisnar, Vladimir, Hajek, Roman, Pour, Ludek
Publicado 2022

OAB-046: COVID-19 infection in multiple myeloma patients – retrospective analysis of 371 Czech patients

por Radocha, Jakub, Špička, Ivan, Pour, Luděk, Jelinek, Tomas, Jungova, Alexandra, Minarik, Jiri, Heindorfer, Adriana, Stejskal, Lukas, Ullrychova, Jana, Obernauerova, Jarmila, Kessler, Petr, Wrobel, Marek, Pavlíček, Petr, Sykora, Michal, Mikula, Peter, Maisnar, Vladimir, Hájek, Roman
Publicado 2021

Identification of patients at high risk of secondary extramedullary multiple myeloma development

por Stork, Martin, Sevcikova, Sabina, Minarik, Jiri, Krhovska, Petra, Radocha, Jakub, Pospisilova, Lenka, Brozova, Lucie, Jarkovsky, Jiri, Spicka, Ivan, Straub, Jan, Pavlicek, Petr, Jungova, Alexandra, Jelinek, Tomas, Sandecka, Viera, Maisnar, Vladimir, Hajek, Roman, Pour, Ludek
Publicado 2021

Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis

por Stork, Martin, Spicka, Ivan, Radocha, Jakub, Minarik, Jiri, Jelinek, Tomas, Jungova, Alexandra, Pavlicek, Petr, Pospisilova, Lenka, Sedlak, Frantisek, Straub, Jan, Pika, Tomas, Knechtova, Zdenka, Fidrichova, Anna, Boichuk, Ivanna, Sevcikova, Sabina, Maisnar, Vladimir, Hajek, Roman, Pour, Ludek
Publicado 2023

P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS

por Miguel, Enrique Maria Ocio San, Efebera, Yvonne A., Hájek, Roman, Straub, Jan, Maisnar, Vladimir, Eveillard, Jean-Richard, Karlin, Lionel, Mateos, Maria-Victoria, Oriol, Albert, Ribrag, Vincent, Richardson, Paul, Norin, Stefan, Obermüller, Jakob, Bakker, Nicolaas A., Pour, Ludek
Publicado 2023

Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy

por Minarik, Jiri, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pika, Tomas, Pour, Ludek, Pavlicek, Petr, Harvanova, Lubica, Pospisilova, Lenka, Krhovska, Petra, Novakova, Denisa, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Maisnar, Vladimir, Hajek, Roman
Publicado 2022

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies

por Radocha, Jakub, Maisnar, Vladimír, Pour, Luděk, Špička, Ivan, Minařík, Jiři, Szeligová, Lenka, Pavlíček, Petr, Jungová, Alexandra, Krejčí, Marta, Pika, Tomáš, Straub, Jan, Brožová, Lucie, Stejskal, Lukáš, Heindorfer, Adriana, Jindra, Pavel, Kessler, Petr, Mikula, Peter, Sýkora, Michal, Wróbel, Marek, Jarkovský, Jiří, Hájek, Roman
Publicado 2018

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neurop...

por Minarik, Jiri, Pavlicek, Petr, Pour, Ludek, Pika, Tomas, Maisnar, Vladimir, Spicka, Ivan, Jarkovsky, Jiri, Krejci, Marta, Bacovsky, Jaroslav, Radocha, Jakub, Straub, Jan, Kessler, Petr, Wrobel, Marek, Walterova, Lenka, Sykora, Michal, Obernauerova, Jarmila, Brozova, Lucie, Gregora, Evzen, Adamova, Dagmar, Gumulec, Jaromir, Adam, Zdenek, Scudla, Vlastimil, Hajek, Roman
Publicado 2015

P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY

por Gavriatopoulou, Maria, Spencer, Andrew, Coriu, Daniel, Escalante Barrigón, Fernando, Hájek, Roman, Seguro, Fernanda, Gutiérrez, Norma C., Basic Kinda, Sandra, Offidani, Massimo, Fantl, Dorotea Beatriz Eugenia, Bittencourt, Rosane, Lysén, Anna, Maisnar, Vladimir, Askari, Elham, Martinez-Lopez, Joaquín, Hughes, Olivia, Taylor, Rebekah, Lehn, Kristin, Joehanes, Roby, Ross, Jeremy, Hader, Carlos
Publicado 2023

Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies

por Sandecka, Viera, Popkova, Tereza, Stork, Martin, Maisnar, Vladimir, Minarik, Jiri, Jungova, Alexandra, Pavlicek, Petr, Stejskal, Lukas, Pospisilova, Lenka, Heindorfer, Adriana, Obernauerova, Jarmila, Gregora, Evzen, Sykora, Michal, Ullrychova, Jana, Wrobel, Marek, Kessler, Petr, Jelinek, Tomas, Kunovszki, Peter, Bathija, Sacheeta, Gros, Blanca, Wilbertz, Sabine, Cai, Qian, Lam, Annette, Spicka, Ivan
Publicado 2023

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical...

por Minarik, Jiri, Pika, Tomas, Radocha, Jakub, Jungova, Alexandra, Straub, Jan, Jelinek, Tomas, Pour, Ludek, Pavlicek, Petr, Mistrik, Martin, Brozova, Lucie, Krhovska, Petra, Machalkova, Katerina, Jindra, Pavel, Spicka, Ivan, Plonkova, Hana, Stork, Martin, Bacovsky, Jaroslav, Capkova, Lenka, Sykora, Michal, Kessler, Petr, Stejskal, Lukas, Heindorfer, Adriana, Ullrychova, Jana, Skacel, Tomas, Maisnar, Vladimir, Hajek, Roman
Publicado 2021

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine

por Zátopková, Martina, Ševčíková, Tereza, Fanfani, Viola, Chyra, Zuzana, Říhová, Lucie, Bezděková, Renata, Žihala, David, Growková, Kateřina, Filipová, Jana, Černá, Lucie, Broskevičova, Lucie, Kryukov, Fedor, Minařík, Jiří, Smejkalová, Jana, Maisnar, Vladimír, Harvanová, Ĺubica, Pour, Luděk, Jungova, Alexandra, Popková, Tereza, Bago, Juli Rodriguez, Anilkumar Sithara, Anjana, Hrdinka, Matouš, Jelínek, Tomáš, Šimíček, Michal, Stracquadanio, Giovanni, Hájek, Roman
Publicado 2022